Brief: Galectin Therapeutics Announces $60 Million Credit Line From Richard E. Uihlein Sufficient To Cover Expected Expenditures Through 2024
26/07/2022 13:17
July 26 (Reuters) - Galectin Therapeutics Inc GALT.O :
* GALECTIN THERAPEUTICS ANNOUNCES $60 MILLION CREDIT LINE
FROM
RICHARD E. UIHLEIN SUFFICIENT TO COVER EXPECTED EXPENDITURES
THROUGH 2024
* GALECTIN THERAPEUTICS INC - WILL ISSUE UP TO 1.2 MILLION
STOCK
PURCHASE WARRANTS TO UIHLEIN RATABLY
Source text for Eikon: ID:nGNX79Zl6t
Further company coverage: GALT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study